The cytoplasmic translocation of the NPM1 mutants in AML patients is accompanied by upregulation of HOXA/B genes and alters the hematopoietic cells’ genome topology, as previously mentioned [12]. This evidence concerns the gene NPM1 and acute myeloid leukemia.